Company Filing History:
Years Active: 2025
Title: Elsamani I Abdelfadiel: Innovator in Anti-Cancer Research
Introduction
Elsamani I Abdelfadiel is a notable inventor based in Richmond, VA (US). He has made significant contributions to the field of cancer research, particularly in developing innovative therapeutic agents. His work focuses on targeting cancer stem cells, which are often resistant to conventional treatments.
Latest Patents
Abdelfadiel holds a patent for "Lipidic analogs of anti-cancer stem cell agent." This patent describes a group of specific sulfated flavonoid agents that carry cholesterol modifications. These compounds demonstrate promising in vivo anti-cancer activity through the selective inhibition of cancer stem cells, while sparing adult or hematopoietic stem cells. The agents exhibit high potency, excellent oral bioavailability, and a physiologically relevant therapeutic window. He has 1 patent to his name.
Career Highlights
Abdelfadiel is affiliated with Virginia Commonwealth University, where he conducts his research. His work has garnered attention for its potential to revolutionize cancer treatment by targeting the root causes of cancer cell proliferation.
Collaborations
He collaborates with esteemed colleagues, including Umesh R Desai and Balaji Nagarajan, to further advance his research and develop effective cancer therapies.
Conclusion
Elsamani I Abdelfadiel is a pioneering inventor whose work in anti-cancer research holds great promise for future therapies. His innovative approach to targeting cancer stem cells could lead to more effective treatments for patients.